News

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Arise News15m
US FDA Approves Moderna’s Next-Generation COVID Vaccine For Adults Aged 65 And Above
The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for individuals aged ...
Free Malaysia Today on MSN50m
US FDA approves Moderna’s next-gen mNEXSPIKE Covid vaccine for adults 65 and older, high-risk individuals
Moderna Covid vaccine approved for those 12-64 with risk factors Moderna expects mNEXSPIKE to be ready for 2025-2026 season ...